Bradley Foster & Sargent’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$425K Hold
2,400
0.02% 243
2019
Q4
$459K Buy
2,400
+362
+18% +$65.3K 0.01% 274
2019
Q3
$343K Sell
2,038
-465
-19% -$75.8K 0.01% 287
2019
Q2
$419K Sell
2,503
-157
-6% -$21.7K 0.01% 275
2019
Q1
$390K Sell
2,660
-401
-13% -$58.1K 0.01% 280
2018
Q4
$409K Sell
3,061
-922
-23% -$151K 0.02% 271
2018
Q3
$759K Sell
3,983
-195
-5% -$35.8K 0.03% 245
2018
Q2
$697K Sell
4,178
-1,437
-26% -$231K 0.03% 250
2018
Q1
$945K Sell
5,615
-1,718
-23% -$288K 0.04% 224
2017
Q4
$1.2M Sell
7,333
-32,768
-82% -$5.88M 0.04% 201
2017
Q3
$8.22M Buy
40,101
+5,362
+15% +$1.25M 0.31% 85
2017
Q2
$8.45M Buy
34,739
+26,586
+326% +$6.25M 0.34% 79
2017
Q1
$1.95M Buy
8,153
+1,168
+17% +$272K 0.08% 158
2016
Q4
$1.47M Buy
6,985
+1,784
+34% +$370K 0.06% 175
2016
Q3
$1.2M Buy
5,201
+510
+11% +$125K 0.05% 176
2016
Q2
$1.08M Buy
4,691
+1,358
+41% +$313K 0.05% 177
2016
Q1
$893K Buy
+3,333
New +$954K 0.04% 198

Other funds holding AGN

Bradley Foster & Sargent's AGN Position: Q1 2020 in Review

Bradley Foster & Sargent held its Allergan plc (AGN) position steady in Q1 2020 at 2,400 shares worth $425K. The position accounts for 0.02% of the portfolio, ranked #243.

Bradley Foster & Sargent first reported a position in AGN in Q1 2016 and has held it in 17 quarters since. The position peaked at $8.45M in Q2 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Bradley Foster & Sargent held 2,400 shares of Allergan plc worth $425K as of Q1 2020.
  • Bradley Foster & Sargent left its Allergan plc share count unchanged in Q1 2020.
  • Allergan plc made up 0.02% of Bradley Foster & Sargent's portfolio in Q1 2020, its #243 holding.
  • Bradley Foster & Sargent first reported a position in Allergan plc in Q1 2016 and has held it in 17 quarters since.
  • Bradley Foster & Sargent's Allergan plc position peaked at $8.45M in Q2 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Bradley Foster & Sargent's 13F filing for Q1 2020, filed 7 May 2020.